[go: up one dir, main page]

WO2004112714A3 - Chemical compounds - Google Patents

Chemical compounds Download PDF

Info

Publication number
WO2004112714A3
WO2004112714A3 PCT/US2004/019388 US2004019388W WO2004112714A3 WO 2004112714 A3 WO2004112714 A3 WO 2004112714A3 US 2004019388 W US2004019388 W US 2004019388W WO 2004112714 A3 WO2004112714 A3 WO 2004112714A3
Authority
WO
WIPO (PCT)
Prior art keywords
chemical compounds
compositions
medicaments
thienopyrimidine derivatives
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2004/019388
Other languages
French (fr)
Other versions
WO2004112714A2 (en
Inventor
Jennifer G Badiang
Scott Howard Dickerson
Kelly Horne Donaldson
Kevin Wayne Hinkle
Keith Robert Hornberger
Kimberly Glennon Petrov
Michael John Reno
Kirk Lawrence Stevens
David Edward Uehling
Alex Gregory Waterson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of WO2004112714A2 publication Critical patent/WO2004112714A2/en
Publication of WO2004112714A3 publication Critical patent/WO2004112714A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

The present invention discloses thienopyrimidine derivatives, compositions and medicaments containing the same, as well as processes for the preparation and use of such compounds, compositions and medicaments. Such thienopyrimidine derivatives are useful in the treatment of diseases associated with inappropriate ErbB family kinase activity.
PCT/US2004/019388 2003-06-18 2004-06-17 Chemical compounds Ceased WO2004112714A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47956703P 2003-06-18 2003-06-18
US60/479,567 2003-06-18

Publications (2)

Publication Number Publication Date
WO2004112714A2 WO2004112714A2 (en) 2004-12-29
WO2004112714A3 true WO2004112714A3 (en) 2005-04-07

Family

ID=33539192

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/019388 Ceased WO2004112714A2 (en) 2003-06-18 2004-06-17 Chemical compounds

Country Status (1)

Country Link
WO (1) WO2004112714A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003070241A1 (en) 2002-02-15 2003-08-28 Rigel Pharmaceuticals, Inc. Inhibitors of tubulin polymerization
US7776869B2 (en) * 2004-10-18 2010-08-17 Amgen Inc. Heteroaryl-substituted alkyne compounds and method of use
WO2013012918A1 (en) 2011-07-19 2013-01-24 Infinity Pharmaceuticals Inc. Heterocyclic compounds and uses thereof
CN106995452B (en) * 2016-12-22 2018-03-16 湖北民族学院 Double target spot inhibitor of a kind of thieno [3,2 d] miazines EGFR/ErbB2 and its production and use

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003053446A1 (en) * 2001-12-19 2003-07-03 Smithkline Beecham Corporation Thienopyrimidine compounds as protein tyrosine kinase inhibitors

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003053446A1 (en) * 2001-12-19 2003-07-03 Smithkline Beecham Corporation Thienopyrimidine compounds as protein tyrosine kinase inhibitors

Also Published As

Publication number Publication date
WO2004112714A2 (en) 2004-12-29

Similar Documents

Publication Publication Date Title
WO2004112719A3 (en) Chemical compounds
WO2004084813A3 (en) Chemical compounds
WO2004074244A3 (en) Pyrimidine compounds
WO2003095455A3 (en) Substituted pyrazolopyrimidines
IL173348A (en) Thienopyridine compounds, pharmaceutical compositions comprising same and use thereof in the preparation of medicaments
WO2003049702A8 (en) Vanilloid receptor ligands and their use in treatments
WO2006032342A3 (en) Carbonyl compound-containing drug and the use thereof
WO2002102793A3 (en) Quinazolinediones as antibacterial agents
WO2005049581A8 (en) Pyridazin-3 (2h) -one derivatives and their use as pde4 inhibitors
WO2006086562A3 (en) Phenylazetidinone derivatives
WO2004006858A3 (en) Compounds, compositions, and methods employing same
WO2005004818A3 (en) Heterocyclic compounds and their use as anticancer agents
WO2003000699A8 (en) Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives as medicaments for the treatment of pain
AU2003222786A1 (en) Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions
TW200510392A (en) Chemical compounds
WO2005040171A8 (en) Pyrazolo and imidazo-pyrimidine derivatives
WO2004026836A8 (en) 1-pyridin-4-yl-urea derivatives
WO2005023815A3 (en) Neuroprotective bicyclic compounds and methods for their use
TW200505452A (en) Chemical compounds
ZA200506422B (en) Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use of the same as medicaments, and medicament containing such compounds
WO2005007083A3 (en) Chemical compounds
WO2003072541A3 (en) Chemical compounds
WO2005055939A3 (en) Vinca derivatives
WO2003045324A3 (en) 14-methyl-epothilones
WO2006044753A3 (en) Chemical compounds

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase